http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108976223-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0152623cff45c7c58e9c47b65ea4ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
filingDate 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d824db3d1b2f89cc72255d5f8c8784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe44636d33714db05e5e8bf4de2e001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58f102596382064a14fa05b3955d763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d9628696e608e31d73029129298739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9caf4ef3b156c8d8149f8c510209335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e733720fb958df3863e9425f3348a98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e0e67456f1094530d822a330b28eb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e789317a5ecf4afb5070a062ec0466f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f347195b7948c0f0e5ddc09f49232f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be7eabc236aaa44b6e740e17de0dc4a0
publicationDate 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108976223-A
titleOfInvention Fused tricyclic compounds and their application in medicine
abstract The invention relates to a condensed tricyclic compound and its application in medicine, especially the application as a medicine for treating and/or preventing hepatitis B. Specifically, the present invention relates to a compound represented by general formula (I) or its stereoisomer, tautomer, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug, Wherein each variable is as defined in the specification. The present invention also relates to the use of the compound represented by the general formula (I) or its stereoisomer, tautomer, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug as a drug , especially as a medicament for the treatment and/or prevention of hepatitis B.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999224-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114014854-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110862390-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110862390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114014854-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111943946-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10966970-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110724140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115894252-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111943946-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3909951-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110950860-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110950860-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999224-A
priorityDate 2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107759585-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016128335-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105899508-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016071215-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163473232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467299254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406975405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465400059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137352336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163896373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448622189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146735624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465639720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465031302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141732155

Total number of triples: 55.